Both CCL22 and CCL17, which are produced by tumor cells, tumor-associated macrophages, and dendritic cells, establish a concentration gradient around the tumor mass and attract CCR4+ Tregs to maintain immunological homeostasis in the tumor vicinity (29–31). This evidence concerns the gene CCL22 and neoplasm.